Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term ANTITUMOR-ACTIVITY. Found 5 abstracts

Blay JY, von Mehren M, Samuels BL, Fanucchi MP, Ray-Coquard I, Buckley B, Gilles L, Lebedinsk C, Elsayed YA, Le Cesne A. Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma. Clinical Cancer Research. 2008 Oct;14(20):6656-62.
Armstrong DK, Bookman MA, McGuire W, Bristow RE, Schilder JM. A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study. Gynecologic Oncology. 2007 Jun;105(3):667-71.
Khazak V, Astsaturov I, Serebriiskii IG, Golemis EA. Selective Raf inhibition in cancer therapy. Expert Opinion on Therapeutic Targets. 2007 Dec;11(12):1587-609.
Weiner LM. Opinion - Building better magic bullets - improving unconjugated monoclonal antibody therapy for cancer. Nature Reviews Cancer. 2007 Sep;7(9):701-6.
Schilder RJ, Blessing JA, Pearl ML, Rose PG. Evaluation of irofulven (MGI-114) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology Group. Investigational New Drugs. 2004 Aug;22(3):343-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term ANTITUMOR-ACTIVITY

Last updated on Thursday, April 02, 2020